Image of a healthcare professioanl in mask and gloves at a monitor to show Diabetes inpatient care during COVID-19

Diabetes inpatient care during COVID-19

A new Diabetes UK review into diabetes inpatient care during COVID-19 has revealed that disruption to inpatient diabetes services created positive environments and opportunities...
Image of a hospital corridor with people in the backgound and a drip in the foreground to show The King's Fund comments on NHS performance data

The King’s Fund comments on NHS performance data

The King's Fund has commented on the monthly NHS performance data on accident and emergency, referral to treatment and diagnostics which shows the impact...
Image of a healthcare professional in PPE washing their hands to show Impact of long-term COVID-19 symptoms on patients and doctors

Long-term COVID-19 symptoms in patients and doctors

Data released today as part of the BMA’s latest survey of doctors during the pandemic reveals significant levels of long-term COVID-19 symptoms in patients...
Image of a heart in the body with the mechanics of the circulatory system to show Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Image of business people nurturing plants growing with light bulbs at the top to show Primary care networks and mental health services post COVID-19

Primary care networks and mental health services post COVID-19

Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
Image f a healthcare professional holding tablets to show Common chronic pain treatments 'can do more harm than good'

Common chronic pain treatments ‘can do more harm than good’

A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE...
Iage of a healthcare professional in PPE to show Roll out of rapid coronavirus tests ahead of winter

Roll out of rapid coronavirus tests ahead of winter

Millions of rapid coronavirus tests will be rolled out to hospitals, care homes and labs across the UK to increase testing capacity ahead of...
Woman with mask on phone: use of electronic prescribing

Accelerated use of electronic prescribing

Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
Image of a lab technician at a table with a microscope and medical glassware to show New study into link between IBD and risk of colorectal cancers at molecular level

New study into link between IBD and colorectal cancers

In a new study, researchers have compared diseased colon tissue with healthy tissue to better understand how IBD is linked to an increased risk of...
Image of a heart in the body operating as a machine with mechanical parts coming off of it to show Bridging the gap in heart failure awareness

Bridging the gap in heart failure awareness

The World Heart Federation (WHF) and AstraZeneca have published a new Heart Failure Gap Report bridging the gap in heart failure awareness. While heart failure...

Latest articles

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription